Mycoses D009181

Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Mycoses

Description

Diseases caused by FUNGI.   MeSH

Hierarchy View

Subtype Terms (19)

Aspergillosis
21 drugs (16 approved, 5 experimental)

Candidiasis
41 drugs (25 approved, 16 experimental)

Central Nervous System Fungal Infections
2 approved drugs

Coccidioidomycosis
11 drugs (8 approved, 3 experimental)

Cryptococcosis
5 approved drugs

Dermatomycoses
6 drugs (4 approved, 2 experimental)

Eye Infections, Fungal
3 drugs (2 approved, 1 experimental)

Geotrichosis
 

Histoplasmosis
4 approved drugs

Invasive Fungal Infections
18 drugs (10 approved, 8 experimental)

Lung Diseases, Fungal
4 drugs (3 approved, 1 experimental)

Microsporidiosis
1 experimental drug

Otomycosis
8 drugs (2 approved, 6 experimental)

Paracoccidioidomycosis
 

Phaeohyphomycosis
 

Piedra
 

Pneumocystis Infections
5 drugs (4 approved, 1 experimental)

Trichosporonosis
 

Zygomycosis
1 approved drug



Organization Involved with Phase 2 Indications (79)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.